Biocon Balance Sheet Health
Financial Health criteria checks 1/6
Biocon has a total shareholder equity of ₹242.8B and total debt of ₹182.5B, which brings its debt-to-equity ratio to 75.2%. Its total assets and total liabilities are ₹545.8B and ₹303.0B respectively. Biocon's EBIT is ₹20.2B making its interest coverage ratio 2.3. It has cash and short-term investments of ₹37.9B.
Key information
75.2%
Debt to equity ratio
₹182.52b
Debt
| Interest coverage ratio | 2.3x |
| Cash | ₹37.86b |
| Equity | ₹242.77b |
| Total liabilities | ₹303.00b |
| Total assets | ₹545.77b |
Recent financial health updates
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13
Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Is Biocon (NSE:BIOCON) Using Too Much Debt?
Mar 28Biocon (NSE:BIOCON) Seems To Use Debt Quite Sensibly
Dec 27Recent updates
Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Mar 20Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price
Jan 23Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price
Jan 03These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Aug 03Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)
Mar 28Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate
Dec 17Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?
Sep 05Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
May 26Is Biocon (NSE:BIOCON) Using Too Much Debt?
Mar 28Biocon (NSE:BIOCON) Seems To Use Debt Quite Sensibly
Dec 27Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Nov 25Financial Position Analysis
Short Term Liabilities: BIOCON's short term assets (₹140.7B) exceed its short term liabilities (₹103.7B).
Long Term Liabilities: BIOCON's short term assets (₹140.7B) do not cover its long term liabilities (₹199.3B).
Debt to Equity History and Analysis
Debt Level: BIOCON's net debt to equity ratio (59.6%) is considered high.
Reducing Debt: BIOCON's debt to equity ratio has increased from 34.2% to 75.2% over the past 5 years.
Debt Coverage: BIOCON's debt is not well covered by operating cash flow (6.4%).
Interest Coverage: BIOCON's interest payments on its debt are not well covered by EBIT (2.3x coverage).